LBDE has been reported to suppress breast cancer metastases and bone microenvironment by inhibiting the parathyroid hormone-related protein (PTHrP), matrix metallopeptidase 9 (MMP-9) and cathepsin K activities in breast cancer cells and osteoclastic bone resorption [14]. Here, CTSK is linked to breast cancer.